Ellis et ellis E El Ell Elli BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 0 0 . 1 3 0 1 0 0 1
Allergy Asthma allergy A Al All Alle BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 6 0 1 0 0 1
(2020) 16:15 (2020) ( (2 (20 (202 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 0 0 (): 3 3 0 1 0 0 1
https://doi.org/10.1186/s13223-020-0412-8 https://doi.org/10.1186/s13223-020-0412-8 https://doi.org/10.1186/s13223-020-0412-8 h ht htt http BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 1 0 0 ://././--- 10 10 0 1 0 0 1
RESEARCH RESEARCH research R RE RES RESE BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 ALLCAP NODIGIT 0 1 1 0 0 0 0 0 0 0 no 0 10 0 1 0 0 1
Patient and patient P Pa Pat Pati BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 7 0 0 0 0 1
of seasonal of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 9 0 0 0 0 1
immunotherapy: a immunotherapy: i im imm immu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 : 1 10 0 0 0 0 1
survey survey survey s su sur surv BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 1 0 0 0 0 1
Anne K. anne A An Ann Anne BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 0 0 .*,,,- 6 10 0 0 0 0 1
Abstract Abstract abstract A Ab Abs Abst BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 1 no 0 0 0 0 0 0 1
Background: The background: B Ba Bac Back BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 1 :() 3 9 0 0 0 0 1
patient survey. patient p pa pat pati BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 . 1 9 0 0 0 0 1
and their and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 ,() 3 9 0 0 0 0 1
seasonal allergies. seasonal s se sea seas BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 1 .' 2 10 0 0 0 0 1
University. University. university. U Un Uni Univ BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 1 . 1 1 0 0 0 0 1
Methods: Allergists methods: M Me Met Meth BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 2 :()- 4 9 0 0 0 0 1
to collect to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 2 . 1 9 0 0 0 0 1
paper-based parallel paper-based p pa pap pape BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 2 -. 2 10 0 0 0 0 1
questionnaire. Patients questionnaire. q qu que ques BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 2 .- 2 9 0 0 0 0 1
inclusion criteria. inclusion i in inc incl BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 2 . 1 1 0 0 0 0 1
Results: The results: R Re Res Resu BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 3 :. 2 9 0 0 0 0 1
surveys were surveys s su sur surv BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 3 .(-).- 6 9 0 0 0 0 1
reported prior reported r re rep repo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 3 .- 2 9 0 0 0 0 1
duration and duration d du dur dura BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 3 ,.- 3 10 0 0 0 0 1
indicated they indicated i in ind indi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 3 (), 3 10 0 0 0 0 1
compared to compared c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 3 ()., 4 8 0 0 0 0 1
unlikely or unlikely u un unl unli BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 3 no 0 10 0 0 0 0 1
recommended by recommended r re rec reco BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 3 . 1 2 0 0 0 0 1
Conclusions: In conclusions: C Co Con Conc BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 5 :, 2 9 0 0 0 0 1
to the to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 ..' 3 10 0 0 0 0 1
assessment. When assessment. a as ass asse BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 ., 2 9 0 0 0 0 1
their allergists' their t th the thei BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 '. 2 6 0 0 0 0 1
Keywords: Allergen keywords: K Ke Key Keyw BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 7 :,,,,, 6 10 1 0 0 0 1
rhinitis, Sublingual rhinitis, r rh rhi rhin BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 7 ,, 2 5 1 0 0 0 1
© The © © © © © BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 1 7 ()..,,, 7 9 1 1 0 0 1
adaptation, distribution adaptation, a ad ada adap BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 7 ,,() 4 9 1 1 0 0 1
the source, the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 7 ,,. 3 9 1 1 0 0 1
in this in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 1 7 ',. 3 10 1 1 0 0 1
is not is i is is is BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 7 ' 1 9 1 1 0 0 1
permitted use, permitted p pe per perm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 7 ,.,:// 6 9 1 1 0 0 1
mmons .org/licen mmons m mm mmo mmon BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 7 .///./.(://.// 14 8 1 1 0 0 1
zero/1.0/) applies zero/1.0/) z ze zer zero BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 7 /./),. 6 8 1 1 0 0 1
Introduction Introduction introduction I In Int Intr BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 10 no 0 10 1 0 0 0 1
The number the T Th The The BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 10 no 0 8 1 0 0 0 1
estimated at estimated e es est esti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 10 .[].- 5 10 1 0 0 0 1
diagnosed allergic diagnosed d di dia diag BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 10 no 0 9 1 0 0 0 1
Open Access open O Op Ope Open BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 11 no 0 10 0 1 0 0 1
Allergy, Asthma allergy, A Al All Alle BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 11 , 1 10 0 1 0 0 1
*Correspondence: ellisa@queensu.ca *correspondence: * *C *Co *Cor BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 11 *:@. 4 4 1 0 0 0 1
1 Division 1 1 1 1 1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 2 11 ,,' 3 9 1 0 0 0 1
University, Kingston, university, U Un Uni Univ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 11 ,,, 3 4 1 0 0 0 1
Full list full F Fu Ful Full BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 11 no 0 10 1 0 0 0 1
Page 2 page P Pa Pag Page BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 2 0 no 0 2 0 1 0 0 1
Ellis et ellis E El Ell Elli BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 2 0 . 1 10 0 1 0 0 1
(2020) 16:15 (2020) ( (2 (20 (202 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 2 0 (): 3 3 0 1 0 0 1
structured telephone structured s st str stru BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 no 0 8 0 0 0 0 1
the age the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 []. 3 3 0 0 0 0 1
Allergic rhinitis allergic A Al All Alle BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 0 () 2 8 0 0 0 0 1
burden to burden b bu bur burd BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 2 0 '. 2 8 0 0 0 0 1
burden of burden b bu bur burd BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 2 0 , 1 8 0 0 0 0 1
and diabetes and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 , 1 8 0 0 0 0 1
only to only o on onl only BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 8 0 0 0 0 1
and restriction and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 []. 3 9 0 0 0 0 1
examined the examined e ex exa exam BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 7 0 0 0 0 1
symptoms in symptoms s sy sym symp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 []. 3 9 0 0 0 0 1
reported impaired reported r re rep repo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 / 1 8 0 0 0 0 1
distraction, irritability, distraction, d di dis dist BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 ,, 2 10 0 0 0 0 1
of symptoms of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 []. 3 8 0 0 0 0 1
been found been b be bee been BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 9 0 0 0 0 1
sleep as sleep s sl sle slee BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 , 1 9 0 0 0 0 1
a validated a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 2 0 []. 3 4 0 0 0 0 1
Despite treatment, despite D De Des Desp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 0 , 1 8 0 0 0 0 1
have uncontrolled have h ha hav have BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 . 1 8 0 0 0 0 1
interview of interview i in int inte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 8 0 0 0 0 1
allergic rhinitis, allergic a al all alle BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 , 1 9 0 0 0 0 1
limited despite limited l li lim limi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 9 0 0 0 0 1
61% felt 61% 6 61 61% 61% BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 0 / 1 8 0 0 0 0 1
not controlled not n no not not BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 []. 3 3 0 0 0 0 1
Allergen specific allergen A Al All Alle BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 0 () 2 7 0 0 0 0 1
allergy treatment allergy a al all alle BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 8 0 0 0 0 1
process [6]. process p pr pro proc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 []. 3 8 0 0 0 0 1
Canada, subcutaneous canada, C Ca Can Cana BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 0 ,() 3 6 0 0 0 0 1
via injection, via v vi via via BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 ,() 3 7 0 0 0 0 1
delivered in delivered d de del deli BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 . 1 4 0 0 0 0 1
The Allergy the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 8 0 0 0 0 1
(AsPIRe) Program (aspire) ( (A (As (AsP BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 () 2 7 0 0 0 0 1
differences between differences d di dif diff BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 8 0 0 0 0 1
of seasonal of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 8 0 0 0 0 1
living. The living. l li liv livi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 . 1 9 0 0 0 0 1
attitudes toward attitudes a at att atti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 7 0 0 0 0 1
(AIT) modalities (ait) ( (A (AI (AIT BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 0 ()' 3 9 0 0 0 0 1
offered as offered o of off offe BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 . 1 9 0 0 0 0 1
Methods Methods methods M Me Met Meth BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 4 no 0 10 0 1 0 0 1
Thirty-nine allergists thirty-nine T Th Thi Thir BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 4 - 1 9 0 1 0 0 1
participate in participate p pa par part BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 .- 2 9 0 1 0 0 1
and completed and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 - 1 9 0 1 0 0 1
information and information i in inf info BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 . 1 9 0 1 0 0 1
recruited patients recruited r re rec recr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 :- 2 9 0 1 0 0 1
naïve seasonal naïve n na naï naïv BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 4 no 0 9 0 1 0 0 1
to AIT to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 . 1 6 0 1 0 0 1
For each for F Fo For For BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 4 no 0 8 0 1 0 0 1
and met and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 , 1 8 0 1 0 0 1
patient completed patient p pa pat pati BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 - 1 8 0 1 0 0 1
patient questionnaires. patient p pa pat pati BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 . 1 9 0 1 0 0 1
informational booklet informational i in inf info BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 4 . 1 8 0 1 0 0 1
allergist survey allergist a al all alle BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 4 no 0 10 0 1 0 0 1
survey consisted survey s su sur surv BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 ( 1 9 0 0 0 0 1
Additional files additional A Ad Add Addi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 5 ,). 3 4 0 0 0 0 1
Results were results R Re Res Resu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 4 5 no 0 7 0 0 0 0 1
questions were questions q qu que ques BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 , 1 9 0 0 0 0 1
cross-tabulations of cross-tabulations c cr cro cros BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 - 1 9 0 0 0 0 1
similarities or similarities s si sim simi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 .- 2 9 0 0 0 0 1
was done was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 no 0 8 0 0 0 0 1
patient and patient p pa pat pati BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 .- 2 10 0 0 0 0 1
that is that t th tha that BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 . 1 9 0 0 0 0 1
lack of lack l la lac lack BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 . 1 3 0 0 0 0 1
Following tabulation following F Fo Fol Foll BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 5 no 0 10 0 0 0 0 1
paper-based surveys, paper-based p pa pap pape BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 -, 2 9 0 0 0 0 1
the participating the t th the the BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 . 1 5 0 0 0 0 1
Results Results results R Re Res Resu BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 4 7 no 0 10 0 0 0 0 1
Baseline characteristics baseline B Ba Bas Base BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 7 no 0 10 0 0 0 0 1
The survey the T Th The The BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 7 . 1 10 0 0 0 0 1
A total a A A A A BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 1 0 0 0 0 0 4 7 no 0 10 0 0 0 0 1
were completed. were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 7 . 1 8 0 0 0 0 1
returned was returned r re ret retu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 7 ,, 2 8 0 0 0 0 1
24% and 24% 2 24 24% 24% BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 7 . 1 9 0 0 0 0 1
was 30 was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 7 (-),, 5 8 0 0 0 0 1
56% female. 56% 5 56 56% 56% BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 7 . 1 9 0 0 0 0 1
of longer of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 7 no 0 9 0 0 0 0 1
patients, 46% patients, p pa pat pati BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 7 ,. 2 8 0 0 0 0 1
Impact of impact I Im Imp Impa BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 8 no 0 10 0 0 0 0 1
When questioned when W Wh Whe When BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 8 , 1 9 0 0 0 0 1
both patients both b bo bot both BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 no 0 9 0 0 0 0 1
most bothersome. most m mo mos most BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 .-, 3 8 0 0 0 0 1
calculated and calculated c ca cal calc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 (.) 3 9 0 0 0 0 1
sneezing (3.7) sneezing s sn sne snee BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 (.) 3 9 0 0 0 0 1
rated blocked rated r ra rat rate BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 (.)(.) 6 8 0 0 0 0 1
most bothersome. most m mo mos most BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 ., 2 8 0 0 0 0 1
and quality and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 no 0 9 0 0 0 0 1
patients and patients p pa pat pati BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 . 1 9 0 0 0 0 1
and allergist and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 no 0 8 0 0 0 0 1
most bothersome most m mo mos most BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 (- 2 8 0 0 0 0 1
p = p p p p p BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 5 8 .). 3 1 0 0 0 0 1
Analysis of analysis A An Ana Anal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 8 no 0 9 0 0 0 0 1
reported being reported r re rep repo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 no 0 8 0 0 0 0 1
6-7 days 6-7 6 6- 6-7 6-7 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 8 -, 2 10 0 0 0 0 1
suffered with suffered s su suf suff BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 (.). 4 10 0 0 0 0 1
and patients and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 no 0 8 0 0 0 0 1
work and work w wo wor work BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 no 0 9 0 0 0 0 1
impacted on impacted i im imp impa BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 8 . 1 8 0 0 0 0 1
Awareness of awareness A Aw Awa Awar BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 11 no 0 10 0 1 0 0 1
Fifty-eight percent fifty-eight F Fi Fif Fift BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 11 - 1 10 0 1 0 0 1
of AIT of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 11 . 1 9 0 1 0 0 1
were aware were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 11 , 1 8 0 1 0 0 1
allergist while allergist a al all alle BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 11 no 0 9 0 1 0 0 1
Page 3 page P Pa Pag Page BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 6 0 no 0 2 0 1 0 0 1
Ellis et ellis E El Ell Elli BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 6 0 . 1 10 0 1 0 0 1
(2020) 16:15 (2020) ( (2 (20 (202 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 6 0 (): 3 3 0 1 0 0 1
and family and a an and and BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 (.)., 5 10 0 0 0 0 1
made aware made m ma mad made BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 0 . 1 5 0 0 0 0 1
Patient preference patient P Pa Pat Pati BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 1 no 0 10 0 1 0 0 1
Patient responses patient P Pa Pat Pati BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 1 no 0 9 0 1 0 0 1
they would they t th the they BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 1 no 0 9 0 1 0 0 1
immunotherapy (SLIT) immunotherapy i im imm immu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 1 () 2 9 0 1 0 0 1
compared to compared c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 1 no 0 8 0 1 0 0 1
(SCIT) (Figs. (scit) ( (S (SC (SCI BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 1 ()(.). 6 4 0 1 0 0 1
Conversely, 8% conversely, C Co Con Conv BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 1 , 1 8 0 1 0 0 1
unlikely or unlikely u un unl unli BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 1 no 0 9 0 1 0 0 1
of patients of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 1 no 0 10 0 1 0 0 1
SCIT if scit S SC SCI SCIT BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 1 . 1 6 0 1 0 0 1
Discussion Discussion discussion D Di Dis Disc BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 4 no 0 10 0 0 0 0 1
Comparing the comparing C Co Com Comp BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 4 no 0 8 0 0 0 0 1
demonstrated a demonstrated d de dem demo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 no 0 8 0 0 0 0 1
and their and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 no 0 9 0 0 0 0 1
on daily on o on on on BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 .,, 3 10 0 0 0 0 1
patients were patients p pa pat pati BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 no 0 9 0 0 0 0 1
allergy symptoms allergy a al all alle BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 - 1 8 0 0 0 0 1
week. The week. w we wee week BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 . 1 8 0 0 0 0 1
on daily on o on on on BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 no 0 8 0 0 0 0 1
reported by reported r re rep repo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 no 0 9 0 0 0 0 1
significance. This significance. s si sig sign BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 . 1 9 0 0 0 0 1
well controlled well w we wel well BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 . 1 8 0 0 0 0 1
To provide to T To To To BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 4 , 1 9 0 0 0 0 1
their management their t th the thei BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 no 0 7 0 0 0 0 1
allergists and allergists a al all alle BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 4 , 1 9 0 0 0 0 1
Fig. 1 fig. F Fi Fig Fig. BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 9 .: 2 10 0 0 0 0 1
life (daily life l li lif life BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 9 (/--) 5 8 0 0 0 0 1
Fig. 2 fig. F Fi Fig Fig. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 10 .: 2 10 0 0 0 0 1
Fig. 3 fig. F Fi Fig Fig. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 10 .: 2 10 0 0 0 0 1
patient likelihood patient p pa pat pati BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 10 no 0 3 0 0 0 0 1
Fig. 4 fig. F Fi Fig Fig. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 11 .: 2 10 0 0 0 0 1
patient likelihood patient p pa pat pati BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 11 no 0 3 0 0 0 0 1
Page 4 page P Pa Pag Page BLOCKSTART PAGESTART NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 7 0 no 0 2 0 0 0 0 1
Ellis et ellis E El Ell Elli BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 7 0 . 1 10 0 0 0 0 1
(2020) 16:15 (2020) ( (2 (20 (202 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 7 0 (): 3 3 0 0 0 0 1
therapeutic options. therapeutic t th the ther BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 . 1 8 1 0 0 0 1
and Clinical and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 no 0 8 1 0 0 0 1
should be should s sh sho shou BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 no 0 9 1 0 0 0 1
airway symptoms airway a ai air airw BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 no 0 9 1 0 0 0 1
who have who w wh who who BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 no 0 9 1 0 0 0 1
tolerated conventional tolerated t to tol tole BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 , 1 9 1 0 0 0 1
to be to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 -[]. 4 8 1 0 0 0 1
Patients showed patients P Pa Pat Pati BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 0 no 0 8 1 0 0 0 1
SCIT if scit S SC SCI SCIT BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 . 1 9 1 0 0 0 1
of patients of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 no 0 10 1 0 0 0 1
SCIT if scit S SC SCI SCIT BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 . 1 8 1 0 0 0 1
In contrast, in I In In In BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 7 0 , 1 9 1 0 0 0 1
at all at a at at at BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 ' 1 9 1 0 0 0 1
to initiate to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 . 1 9 1 0 0 0 1
preference for preference p pr pre pref BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 .[] 3 8 1 0 0 0 1
their discrete their t th the thei BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 no 0 9 1 0 0 0 1
physician visits physician p ph phy phys BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 no 0 9 1 0 0 0 1
preferred attributes preferred p pr pre pref BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 . 1 5 1 0 0 0 1
There are there T Th The Ther BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 0 ., 2 9 1 0 0 0 1
had a had h ha had had BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 . 1 8 1 0 0 0 1
Allergists who allergists A Al All Alle BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 no 0 8 1 0 0 0 1
known to known k kn kno know BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 no 0 8 1 0 0 0 1
in studies in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 7 0 . 1 7 1 0 0 0 1
representation was representation r re rep repr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 no 0 8 1 0 0 0 1
surveys were surveys s su sur surv BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 no 0 9 1 0 0 0 1
the provinces the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 ,, 2 9 1 0 0 0 1
Quebec. A quebec. Q Qu Que Queb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 .- 2 8 1 0 0 0 1
patient selection. patient p pa pat pati BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 . 1 9 1 0 0 0 1
individual patients individual i in ind indi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 no 0 8 1 0 0 0 1
this could this t th thi this BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 ., 2 9 1 0 0 0 1
while the while w wh whi whil BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 - 1 9 1 0 0 0 1
patient survey patient p pa pat pati BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 no 0 9 1 0 0 0 1
members based members m me mem memb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 , 1 9 1 0 0 0 1
in English in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 7 0 , 1 9 1 0 0 0 1
were not were w we wer were BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 . 1 4 1 0 0 0 1
Conclusions Conclusions conclusions C Co Con Conc BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 3 no 0 10 1 0 0 0 1
In this in I In In In BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 8 3 , 1 8 1 0 0 0 1
perception between perception p pe per perc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 3 no 0 9 1 0 0 0 1
impact of impact i im imp impa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 3 . 1 10 1 0 0 0 1
being more being b be bei bein BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 3 ' 1 9 1 0 0 0 1
assessment. When assessment. a as ass asse BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 3 . 1 8 1 0 0 0 1
options, this options, o op opt opti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 3 , 1 9 1 0 0 0 1
were more were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 3 ' 1 10 1 0 0 0 1
for initiation for f fo for for BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 3 . 1 6 1 0 0 0 1
Supplementary information supplementary S Su Sup Supp BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 4 no 0 10 1 1 0 0 1
Supplementary information supplementary S Su Sup Supp BLOCKSTART PAGEIN SAMEFONT LOWERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 4 ://. 4 10 0 1 0 0 1
org/10.1186/s1322 3-020-0412-8. org/10.1186/s1322 o or org org/ BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 1 0 0 0 8 4 /./---. 7 4 0 1 0 0 1
Additional file additional A Ad Add Addi BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 4 .. 2 10 0 1 0 0 1
Additional file additional A Ad Add Addi BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 4 .. 2 10 0 1 0 0 1
Acknowledgements Acknowledgements acknowledgements A Ac Ack Ackn BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 5 no 0 2 0 1 0 0 1
Acknowledgement of acknowledgement A Ac Ack Ackn BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 5 no 0 10 0 1 0 0 1
Lamont. Lamont. lamont. L La Lam Lamo BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 5 . 1 1 0 1 0 0 1
Authors' contributions authors' A Au Aut Auth BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 5 ' 1 2 0 1 0 0 1
All authors all A Al All All BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 5 , 1 8 0 1 0 0 1
interpretation of interpretation i in int inte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 5 ., 2 9 0 1 0 0 1
acquisition of acquisition a ac acq acqu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 5 .' 2 10 0 1 0 0 1
Sciences and sciences S Sc Sci Scie BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 5 . 1 10 0 1 0 0 1
read and read r re rea read BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 8 5 . 1 5 0 1 0 0 1
Funding Funding funding F Fu Fun Fund BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 5 no 0 1 0 1 0 0 1
Stallergenes Greer stallergenes S St Sta Stal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 () 2 9 0 1 0 0 1
had no had h ha had had BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 ,, 2 10 0 1 0 0 1
writing of writing w wr wri writ BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 . 1 2 0 1 0 0 1
Availability of availability A Av Ava Avai BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 6 no 0 4 0 1 0 0 1
The datasets the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 6 no 0 10 0 1 0 0 1
the corresponding the t th the the BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 . 1 6 0 1 0 0 1
Ethics approval ethics E Et Eth Ethi BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 6 no 0 5 0 0 0 0 1
This study this T Th Thi This BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 6 ' 1 10 0 0 0 0 1
Health Sciences health H He Hea Heal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 9 6 no 0 9 0 0 0 0 1
(DMED-2125-18). (DMED-2125-18). (dmed-2125-18). ( (D (DM (DME BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 6 (--). 5 2 0 0 0 0 1
Competing interests competing C Co Com Comp BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 6 no 0 2 1 0 0 0 1
JB has jb J JB JB JB BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 6 '-,,,, 6 9 1 0 0 0 1
Novartis, Pediapharm, novartis, N No Nov Nova BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 6 ,,,; 4 9 1 0 0 0 1
Aralez and aralez A Ar Ara Aral BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 6 . 1 9 1 0 0 0 1
been on been b be bee been BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 ',/,, 5 8 1 0 0 0 1
Johnson, Nutricia, johnson, J Jo Joh John BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 6 ,,,/;, 6 9 1 0 0 0 1
Meda/Mylan, Sanofi, meda/mylan, M Me Med Meda BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 6 /,,,/,,, 8 9 1 0 0 0 1
ALK; and alk; A AL ALK ALK; BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 6 ;. 2 9 1 0 0 0 1
interests. AKE interests. i in int inte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 .'-,, 5 9 1 0 0 0 1
AstraZeneca, Meda, astrazeneca, A As Ast Astr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 6 ,,,,,,,; 8 9 1 0 0 0 1
received research received r re rec rece BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 ,, 2 10 1 0 0 0 1
Ltd, GSK, ltd, L Lt Ltd Ltd, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 6 ,,,,,,,, 8 9 1 0 0 0 1
and SunPharma, and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 ,-,,., 6 9 1 0 0 0 1
Merck, Mylan, merck, M Me Mer Merc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 6 ,,,,. 5 9 1 0 0 0 1
been on been b be bee been BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 ',. 3 8 1 0 0 0 1
Author details author A Au Aut Auth BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 9 no 0 1 1 0 0 0 1
1 Division 1 1 1 1 1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 10 9 ,,' 3 8 1 0 0 0 1
University, Kingston, university, U Un Uni Univ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 9 ,,,. 4 9 1 0 0 0 1
Immunology, Centre immunology, I Im Imm Immu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 9 ,,, 3 9 1 0 0 0 1
Quebec City, quebec Q Qu Que Queb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 9 ,,.,, 5 10 1 0 0 0 1
Edmonton, AB, edmonton, E Ed Edm Edmo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 9 ,,., 4 9 1 0 0 0 1
of Medicine, of o of of of BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 9 ,,,. 4 6 1 0 0 0 1
Received: 11 received: R Re Rec Rece BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 10 :: 2 10 1 0 0 0 1
References References references R Re Ref Refe BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 10 no 0 1 1 0 0 0 1
1. Statistics 1. 1 1. 1. 1. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 10 .,,,, 5 9 1 0 0 0 1
2018, Catalogue 2018, 2 20 201 2018 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 10 ,.--. 5 3 1 0 0 0 1
2. de 2. 2 2. 2. 2. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 10 .,,,,-, 7 10 1 0 0 0 1
Colas C. colas C Co Col Cola BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 10 . 1 9 1 0 0 0 1
care practice care c ca car care BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 10 : 1 8 1 0 0 0 1
cross-sectional study cross-sectional c cr cro cros BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 10 - 1 9 1 0 0 0 1
compared with compared c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 10 (). 3 8 1 0 0 0 1
Allergy. 2012;26(5):390-4. allergy. A Al All Alle BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 10 .;():-. 7 3 1 0 0 0 1
3. Meltzer 3. 3 3. 3. 3. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 10 .,,. 4 8 1 0 0 0 1
survey assessing survey s su sur surv BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 10 no 0 8 1 0 0 0 1
rhinoconjunctivitis in rhinoconjunctivitis r rh rhi rhin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 10 .. 2 8 1 0 0 0 1
2017;5:779-89. 2017;5:779-89. 2017;5:779-89. 2 20 201 2017 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 10 ;:-. 4 1 1 0 0 0 1
4. Benninger 4. 4 4. 4. 4. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 10 .,. 3 9 1 0 0 0 1
activity, sleep activity, a ac act acti BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 10 ,..;():-. 9 8 1 0 0 0 1
Page 5 page P Pa Pag Page BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 11 0 no 0 2 0 0 0 0 1
Ellis et ellis E El Ell Elli BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 11 0 . 1 10 0 0 0 0 1
(2020) 16:15 (2020) ( (2 (20 (202 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 11 0 (): 3 3 0 0 0 0 1
• fast, • • • • • BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 11 0 •, 2 10 0 1 0 0 1
• thorough • • • • • BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 11 1 • 1 10 0 1 0 0 1
• rapid • • • • • BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 11 1 • 1 10 0 1 0 0 1
• support • • • • • BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 11 2 •, 2 10 0 1 0 0 1
• gold • • • • • BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 11 2 • 1 10 0 1 0 0 1
maximum visibility maximum m ma max maxi BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 3 : 1 10 0 1 0 0 1
• • • • • • • BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 11 4 • 1 10 0 1 0 0 1
At BMC, at A At At At BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 4 ,. 2 10 0 1 0 0 1
Learn more learn L Le Lea Lear BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 4 ./ 2 10 0 1 0 0 1
Ready to ready R Re Rea Read BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 4 ?: 2 10 0 1 0 0 1
5. Keith 5. 5 5. 5. 5. BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 5 .,,,,. 6 9 0 0 0 0 1
of allergic of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 5 ():. 4 10 0 0 0 0 1
Allergy Asthma allergy A Al All Alle BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 5 .;:. 4 5 0 0 0 0 1
6. Canadian 6. 6 6. 6. 6. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 5 ., 2 8 0 0 0 0 1
Manual, Copyright manual, M Ma Man Manu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 5 , 1 8 0 0 0 0 1
Immunology. Immunology. immunology. I Im Imm Immu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 5 . 1 1 0 0 0 0 1
7. Damm 7. 7 7. 7. 7. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 5 .,,-,-,-, 9 9 0 0 0 0 1
et al. et e et et et BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 5 .()- 4 9 0 0 0 0 1
discrete choice discrete d di dis disc BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 5 ..;:. 5 7 0 0 0 0 1
Publisher's Note publisher's P Pu Pub Publ BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 10 ' 1 10 0 0 0 0 1
Springer Nature springer S Sp Spr Spri BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 11 11 no 0 10 0 0 0 0 1
published maps published p pu pub publ BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 11 . 1 6 0 0 0 0 1

